A 22-year-old man is admitted to the intensive care unit for diabetic ketoacidosis. After 14 hours of continuous intravenous regular insulin, aggressive fluid resuscitation, and electrolyte replacement, he is now fully alert, reports no nausea, and is able to tolerate oral intake. The physician orders a reassessment to determine if the patient is ready to transition to a maintenance regimen. Arrange the following treatment evaluation and protocol steps in the correct chronological sequence to safely de-escalate his therapy.
- 1Verify the closure of the anion gap and normalization of venous pH via laboratory monitoring.
- 2Administer the initial dose of scheduled subcutaneous basal insulin.
- 3Maintain the continuous intravenous regular insulin infusion for an overlap period of 1 to 2 hours.
- 4Discontinue the continuous intravenous regular insulin infusion.
- 5Initiate routine point-of-care capillary blood glucose monitoring every 4 hours alongside meals.
Answer
The correct chronological sequence is to first verify the closure of the anion gap and normalization of venous pH, then administer the initial dose of scheduled subcutaneous basal insulin, next maintain the continuous intravenous regular insulin infusion for an overlap period of 1 to 2 hours, subsequently discontinue the continuous intravenous regular insulin infusion, and finally initiate routine point-of-care capillary blood glucose monitoring every 4 hours alongside meals.
Transitioning a patient from an intravenous insulin infusion to a subcutaneous regimen requires careful evaluation and a strict sequence to prevent rebound ketoacidosis. First, the clinical and biochemical resolution of diabetic ketoacidosis must be verified (typically defined as an anion gap ≤ 12 mEq/L, pH > 7.30, bicarbonate ≥ 15 mEq/L, and the ability to eat). Second, a subcutaneous basal insulin dose is administered. Because subcutaneous insulin requires 1 to 2 hours to achieve adequate systemic absorption and physiological effect, the intravenous insulin infusion must be maintained as an overlap during this timeframe. Once the overlap period concludes, the intravenous infusion is safely discontinued. Finally, ongoing evaluation is maintained via serial point-of-care capillary blood glucose checks to manage the patient's ongoing dietary intake and glycemic control.
Step-by-Step Solution
Key Concept
Standard de-escalation protocol and monitoring sequence for transitioning from intravenous to subcutaneous insulin in diabetic ketoacidosis.
Estimated Time:1m 30s